Literature DB >> 12785749

Juvenile parkinsonism.

Ergun Y Uc1, Robert L Rodnitzky.   

Abstract

Juvenile parkinsonism (JP) is a clinically and etiologically heterogeneous entity. Unlike in the adult form, secondary causes, hereditary and metabolic conditions, are the predominant causes of JP. Idiopathic Parkinson's disease is very rare in this age group. In most cases of JP, parkinsonism is accompanied by other neurologic features, such as dystonia, cognitive impairment, seizures, oculomotor and visual dysfunction, and ataxia. Systemic findings, such as liver dysfunction or hepatosplenomegaly, may be present depending on the cause. This review article describes the clinical characteristics, classification, genetic basis, pathophysiology, biochemistry, pathology, and treatment of JP.

Entities:  

Mesh:

Year:  2003        PMID: 12785749     DOI: 10.1016/s1071-9091(02)00011-6

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  4 in total

Review 1.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

2.  Levodopa-Carbidopa Intestinal Gel in Pediatric Parkinson's Disease.

Authors:  Madison Brooks; Emma Carter; Antonio Quiros; Gonzalo Revuelta
Journal:  Mov Disord Clin Pract       Date:  2020-07-07

3.  Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder.

Authors:  Karen Curtin; Annette E Fleckenstein; Brooks R Keeshin; Deborah A Yurgelun-Todd; Perry F Renshaw; Ken R Smith; Glen R Hanson
Journal:  Neuropsychopharmacology       Date:  2018-09-12       Impact factor: 7.853

Review 4.  Secondary dystonia-clinical clues and syndromic associations.

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Mov Disord       Date:  2009-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.